Baranick Brian 4
4 · EXACT SCIENCES CORP · Filed Feb 21, 2025
Insider Transaction Report
Form 4
Baranick Brian
EVP, GM, Precision Oncology
Transactions
- Award
Common Stock
2025-02-20+4,805→ 18,324 total - Exercise/Conversion
Common Stock
2025-02-19+1,729→ 14,487 total - Tax Payment
Common Stock
2025-02-20$50.48/sh−2,437$123,020→ 15,887 total - Exercise/Conversion
Restricted Stock Units
2025-02-19−1,729→ 0 total→ Common Stock (1,729 underlying) - Tax Payment
Common Stock
2025-02-19$49.63/sh−968$48,042→ 13,519 total
Holdings
- 670(indirect: By 401(k))
Common Stock
Footnotes (7)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
- [F3]Represents shares of common stock received upon settlement of a performance share unit award.
- [F4]Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain performance stock units.
- [F5]In addition to the shares of Common Stock reported on this Form 4, which total 16,557 shares, Mr. Baranick also holds, in the aggregate, an additional 63,278 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
- [F6]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F7]Represents a restricted stock unit award granted on February 19, 2021 that vests in four equal annual installments from the grant date.